Our Edinburgh site has just moved its cell-based assay work into new laboratory facilities and has been developing new approaches in neutralizing antibody (NAb) and antibody-dependent cell-mediated cytotoxicity (ADCC) assays.
With the acquisition of Argenta earlier this year, Charles River's asthma expertise and portfolio has expanded to include unique models that reflect the clinical setting.
As of today, Charles River will assume management and operational responsibilities for the Frederick facility and we will continue to breed and maintain the colonies that are currently housed at this facility.
Co-housing is the best form of enrichment for research animals, but large animal telemetry studies routinely use animals that are individually housed during recordings, often due to hardware limitations. Our study shows that using the latest digital hardware, animals can be co-housed during telemetry recordings without loss of study sensitivity
Our newly validated ELISpot and FluoroSpot reader services are some of the most sensitive cellular assays available. With this technology, we now offer an even wider range of services to meet vaccine development needs.
In addition to the standard microscopy technique, we are also now able to measure micronuclei formation via flow cytometry with fast turnaround times.
We are pleased to inform you that www.argentadiscovery.com and www.biofocus.com are now incorporated into the Charles River website, providing you with integrated discovery services information in a single location.
On May 14, we furthered our commitment to the humane care of research animals by joining our industry colleagues in the signing of the final Concordat on Openness on Animal Research in the UK.
Now available on either a C57BL/6 or FVB background strain, TARGATT™ mice are ideal for developing humanized mice, or mice with targeted transgene or reporter gene insertions.
New rapid, high-resolution and quantitative autoradiography of beta-emitting radioisotopes for preclinical rodent CNS models is now available. The analysis can be done as a stand–alone service or to complement in vivo nuclear imaging with SPECT/CT.